I et studie, hvor Riprazo blev anvendt sammen med en ACE- hæmmer i en diabetisk population, var stigningerne i serumkalium dog mere hyppige (5, 5%).
However, in one study where Riprazo was used in combination with an ACEI in a diabetic population, increases in serum potassium were more frequent (5.5%).